14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:NVGN
Delisted

Novogen Limited Fund Forecast

$3.17
+0 (+0%)
At Close: Jan 16, 2018
RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for Novogen Limited Fund and on which exchange is it traded?
The symbol for Novogen Limited is NVGN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Novogen Limited Fund?
Novogen Limited holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Novogen Limited Fund?
Novogen Limited Fund can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Novogen Limited Fund.

What's the current price of Novogen Limited Fund?
As of the end of day on the Jan 16, 2018, the price of an Novogen Limited (NVGN) share was $3.17.

What is the 52-week high and low for Novogen Limited Fund?
The 52-week high for Novogen Limited Fund is $7.60 and the 52-week low is $1.63.
Click to get the best stock tips daily for free!

About Novogen Limited

Novogen Limited engages in the pharmaceutical research and development business in Australia. The company primarily has two drug technology platforms, which include superbenzopyran (SBPs) and anti-tropomyosin (ATMs). Its SBP technology platform offers Cantrixil, an intra-cavity anti-cancer agent for the treatment of ovarian cancer, malignant ascites, and malignant pleural effusion; and Trilexium for the treatment of brain cancers, neuroblastoma, ... NVGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT